Clinical Trial Update: Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL [NA]

View source ↗

Summary

Clinical trial update on using chemotherapy with targeted immunotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Ph+ ALL | NA | Status: NOT_YET_RECRUITING